Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Uncover the best credit cards for cash back rewards. Choose a card that maximizes your savings on everyday purchases.
26,223 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
In 2026, the budget airline reinventing itself is pulling ahead as it monetizes upgrades and smarter distribution, wh...
When a stock slides after earnings, it can signal trouble or opportunity. This article dives into why hims hers stock...
As mortgage costs stay elevated, Opendoor racked up another quarterly loss. Forget opendoor technologies: this turns ...
In the first half, AMD and Intel outpaced Nvidia as investors rotated into laggards. This article breaks down what ha...
Vistra reports record 2025 EBITDA and unveils a 2026 target that points to sustained growth. The company cites long-t...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
A high-profile medical moment reminds everyday savers that finances need resilience. This guide translates that urgen...
The NEOS Nasdaq-100 High Income ETF (QQQI) is delivering a high monthly payout via an option overlay, but the strateg...
Netflix delivers a brighter quarterly outlook and improved unit economics, fueling a fresh rally as investors bet on ...
A 56-year-old couple with $2.7 million saved must rethink withdrawal plans for a 35- to 40-year retirement, adopting ...
A long-term investment thesis centers on a franchise-driven, dividend-growing fast-food operator. The 25-year hold th...